Fig. 9From: Assessment of the protective and ameliorative impact of quercetin nanoparticles against neuronal damage induced in the hippocampus by acroleinNumber of normal pyramidal cells in CA1, CA2, and CA3, and number of normal granular cells in the DG from the studied groups (G1: Control group, G2: acrolein-treated group, G3: quercetin nanoparticle-treated group, G4: ameliorative group, G5: protective group, G6: recovery group). Data are expressed as (mean ± SD), (P < 0.05)Back to article page